Reckitt Benckiser Group (LON:RB) had its price target decreased by stock analysts at Goldman Sachs Group from GBX 6,300 ($82.87) to GBX 6,100 ($80.24) in a report issued on Wednesday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock. Goldman Sachs Group’s target price points to a potential upside of 6.70% from the stock’s previous close.
Several other equities research analysts also recently commented on RB. Deutsche Bank cut their target price on shares of Reckitt Benckiser Group from GBX 7,500 ($98.66) to GBX 7,200 ($94.71) and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Societe Generale dropped their price target on shares of Reckitt Benckiser Group from GBX 5,500 ($72.35) to GBX 5,300 ($69.72) and set a “sell” rating on the stock in a research report on Tuesday, November 26th. Morgan Stanley restated an “overweight” rating and issued a GBX 6,800 ($89.45) price target on shares of Reckitt Benckiser Group in a research report on Sunday, February 9th. UBS Group restated a “neutral” rating on shares of Reckitt Benckiser Group in a research report on Friday, February 21st. Finally, Barclays boosted their price target on shares of Reckitt Benckiser Group from GBX 7,000 ($92.08) to GBX 7,400 ($97.34) and gave the stock an “overweight” rating in a research report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of GBX 6,533.53 ($85.94).
LON:RB opened at GBX 5,717 ($75.20) on Wednesday. The firm’s 50 day simple moving average is GBX 6,265.50 and its 200 day simple moving average is GBX 6,142.57. The company has a debt-to-equity ratio of 85.08, a current ratio of 0.59 and a quick ratio of 0.43. Reckitt Benckiser Group has a one year low of GBX 5,510 ($72.48) and a one year high of GBX 8,191.30 ($107.75). The company has a market cap of $41.44 billion and a PE ratio of 28.70.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: What are the benefits of a balanced fund?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.